Tenofovir Disoproxil vs Viread: Side-by-Side Comparison
Quick answer: Tenofovir Disoproxil and Viread are both nucleotide reverse transcriptase inhibitor (ntrti) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Tenofovir Disoproxil | Viread |
|---|---|---|
| Drug class | Nucleotide reverse transcriptase inhibitor (NtRTI) | Nucleotide reverse transcriptase inhibitor (NtRTI) |
| ATC code | J05AF07 | J05AF07 |
| Primary indications | HIV-1 infection, Chronic hepatitis B | HIV-1 infection, Chronic hepatitis B |
| Mechanism | Nucleotide analog prodrug that, after intracellular phosphorylation, inhibits viral reverse transcriptase by competing with dATP and causing DNA chain termination | Tenofovir disoproxil fumarate is a prodrug that inhibits HIV reverse transcriptase and HBV polymerase via competitive incorporation into viral DNA |
| Common dose | 300 mg once daily orally | 300 mg once daily |
| Detail page | Tenofovir Disoproxil details → | Viread details → |
How to choose between Tenofovir Disoproxil and Viread
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Nucleotide reverse transcriptase inhibitor (NtRTI) on iMedic · Tenofovir Disoproxil full details · Viread full details
Frequently asked questions
Is Tenofovir Disoproxil better than Viread?
Neither is universally 'better.' They are both nucleotide reverse transcriptase inhibitor (ntrti) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Tenofovir Disoproxil to Viread?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Tenofovir Disoproxil and Viread have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Tenofovir Disoproxil and Viread available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.